Despite relying on glycolysis, there is growing evidence that many tumor types still have high levels of mitochondrial energy metabolism and functioning oxidative phosphorylation. One such subset of tumors is melanoma, potentially playing a role in both tumor progression and resistance to therapy. This has led researchers to wonder whether targeting mitochondrial respiration could be…
FDA-Approved treatment options for individuals with ovarian cancer including dosing.
Approved prostate cancer drug treatments including formulations and usual dosing.
FDA-approved oral and injectable treatment options for breast cancer.
Antiemetic treatment chart including drug formulations, strengths, and usual doses for nausea/vomiting.
Chemotherapeutic and biologic agents for the treatment of non-small cell lung cancer (NSCLC).
The ASCO guideline provides updated recommendations for the prevention and management of chemotherapy-induced nausea and vomiting (CINV) based on the emetic risk of the treatment regimen.
A significant amount of progress has been made in improving the treatment of lung cancer and patient outcomes. However, a number of disparities that can have an impact on these persist, including those affecting lung cancer screening. Lung cancer screening is an essential step toward effective treatment and improved survival, but its success depends on…
Breast cancer is an incredibly fraught experience for patients. Even beyond the diagnosis and treatment, the experience can create emotional issues that linger long after remission. Patients can have issues related to body image that can dramatically affect their self-esteem and sexuality as they work to regain a sense of normality in their daily lives.…
